This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Orr, N.
Right arrow Articles by Levine, M. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Orr, N.
Right arrow Articles by Levine, M. M.

 Previous Article  |  Next Article 

Infection and Immunity, August 1999, p. 4290-4294, Vol. 67, No. 8
0019-9567/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.

Expression and Immunogenicity of a Mutant Diphtheria Toxin Molecule, CRM197, and Its Fragments in Salmonella typhi Vaccine Strain CVD 908-htrA

Nadav Orr,dagger James E. Galen, and Myron M. Levine*

Department of Pediatrics, Division of Infectious Diseases and Tropical Pediatrics, Center for Vaccine Development, and Department of Medicine, Division of Geographic Medicine, University of Maryland School of Medicine, Baltimore, Maryland 21201

Received 1 February 1999/Returned for modification 24 March 1999/Accepted 30 April 1999

Mutant diphtheria toxin molecule CRM197 and fragments thereof were expressed in attenuated Salmonella typhi CVD 908-htrA, and the constructs were tested for their ability to induce serum antitoxin. Initially, expressed proteins were insoluble, and the constructs failed to induce neutralizing antitoxin. Soluble CRM197 was expressed at low levels by utilizing the hemolysin A secretion system from Escherichia coli.


* Corresponding author. Mailing address: Center for Vaccine Development, University of Maryland School of Medicine, 685 W. Baltimore St., Baltimore, MD 21201. Phone: (410) 706-7588. Fax: (410) 706-6205. E-mail: MLEVINE{at}UMPPA1.AB.UMD.EDU.

dagger Present address: Army Health Branch Research Unit, Israel Defense Force, Israel.


Infection and Immunity, August 1999, p. 4290-4294, Vol. 67, No. 8
0019-9567/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.



This article has been cited by other articles:

  • Galen, J. E., Zhao, L., Chinchilla, M., Wang, J. Y., Pasetti, M. F., Green, J., Levine, M. M. (2004). Adaptation of the Endogenous Salmonella enterica Serovar Typhi clyA-Encoded Hemolysin for Antigen Export Enhances the Immunogenicity of Anthrax Protective Antigen Domain 4 Expressed by the Attenuated Live-Vector Vaccine Strain CVD 908-htrA. Infect. Immun. 72: 7096-7106 [Abstract] [Full Text]  
  • Lee, C. W., Lee, S. F., Halperin, S. A. (2004). Expression and Immunogenicity of a Recombinant Diphtheria Toxin Fragment A in Streptococcus gordonii. Appl. Environ. Microbiol. 70: 4569-4574 [Abstract] [Full Text]  
  • Garmory, H. S., Titball, R. W., Griffin, K. F., Hahn, U., Bohm, R., Beyer, W. (2003). Salmonella enterica Serovar Typhimurium Expressing a Chromosomally Integrated Copy of the Bacillus anthracis Protective Antigen Gene Protects Mice against an Anthrax Spore Challenge. Infect. Immun. 71: 3831-3836 [Abstract] [Full Text]  
  • Qian, F., Pan, W. (2002). Construction of a tetR-Integrated Salmonella enterica Serovar Typhi CVD908 Strain That Tightly Controls Expression of the Major Merozoite Surface Protein of Plasmodium falciparum for Applications in Human Vaccine Production. Infect. Immun. 70: 2029-2038 [Abstract] [Full Text]  
  • Miyaji, E. N., Mazzantini, R. P., Dias, W. O., Nascimento, A. L. T. O., Marcovistz, R., Matos, D. S., Raw, I., Winter, N., Gicquel, B., Rappuoli, R., Leite, L. C. C. (2001). Induction of Neutralizing Antibodies against Diphtheria Toxin by Priming with Recombinant Mycobacterium bovis BCG Expressing CRM197, a Mutant Diphtheria Toxin. Infect. Immun. 69: 869-874 [Abstract] [Full Text]  
  • Gomez-Duarte, O. G., Pasetti, M. F., Santiago, A., Sztein, M. B., Hoffman, S. L., Levine, M. M. (2001). Expression, Extracellular Secretion, and Immunogenicity of the Plasmodium falciparum Sporozoite Surface Protein 2 in Salmonella Vaccine Strains. Infect. Immun. 69: 1192-1198 [Abstract] [Full Text]  
  • Pickett, T. E., Pasetti, M. F., Galen, J. E., Sztein, M. B., Levine, M. M. (2000). In Vivo Characterization of the Murine Intranasal Model for Assessing the Immunogenicity of Attenuated Salmonella enterica Serovar Typhi Strains as Live Mucosal Vaccines and as Live Vectors. Infect. Immun. 68: 205-213 [Abstract] [Full Text]